2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

 

Drug Derivative Related Products (975):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-120255
    17(R)-HDHA
    17(R)-HDHA (17(R)-HDoHE) is a pro-resolving mediator (SPM). 17(R)-HDHA enhances the differentiation of B cells toward the CD27(+)CD38(+) antibody-secreting cell phenotype, thereby strongly increasing IgM and IgG production by activated B cells. 17(R)-HDHA does not affect cell proliferation and is non-toxic to cells.
    17(R)-HDHA
  • HY-116203
    BN 50739
    BN 50739 is an active compound.
    BN 50739
  • HY-126800
    Glycotriosyl glutamine
    Glycotriosyl glutamine is a synthetic analogue of the Glycopeptide. Glycotriosyl glutamine induces focal glomerulonephritis (FGN) and the appearance of myeloid bodies in the epithelial cells of the podocytes in rats with nephritogenic activity.
    Glycotriosyl glutamine
  • HY-W205320
    β,3-Dihydroxytyrosine
    β,3-Dihydroxytyrosine is an amino acid derivative.
    β,3-Dihydroxytyrosine
  • HY-129969
    AG-1909
    AG-1909 is an active compound.
    AG-1909
  • HY-W592627
    N,N-Diethyl-p-toluamide
    N,N-Diethyl-p-toluamide is an active compound.
    N,N-Diethyl-p-toluamide
  • HY-138104
    SL-164
    SL-164 is a quinazolinone. SL-164 has sedative properties.
    SL-164
  • HY-124084
    SW203668
    SW203668 is a benzothiazole compound, shows anti-tumor activity against lung cancer cell lines (IC50=0.022-0.116 μM).
    SW203668
  • HY-130333
    Tetrahydrohomofolic acid
    Tetrahydrohomofolic acid is an active compound.
    Tetrahydrohomofolic acid
  • HY-163545
    Tc-Me2P
    Tc-Me2P is a 99MTC-labeled acrylamide (PnAO) derivative that contains two 4-methyl-2-nitroimidazole groups. The primary activity of Tc-Me2P is as an imaging agent for tumor hypoxia. By specifically binding to hypoxic regions in tumor tissue, it can be used for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging to detect hypoxia in tumors. Tc-Me2P can be used to study the targeting of different chemical structures in tumors and normal tissues.
    Tc-Me2P
  • HY-140103
    Azidoethyl-SS-ethylalcohol
    Azidoethyl-SS-ethylalcohol is an active compound.
    Azidoethyl-SS-ethylalcohol
  • HY-124908
    HT1042
    HT1042 is an active compound.
    HT1042
  • HY-137219
    Δ12(E)-Prostaglandin D2
    Δ12(E)-Prostaglandin D2 is a derivative of Prostaglandin D2 (HY-101988). Prostaglandin D2 is one of the major Prostaglandins actively produced in the brain of various mammals.
    Δ12(E)-Prostaglandin D2
  • HY-12093
    MMP408
    MMP408 is an active compound.
    MMP408
  • HY-119239
    R 28935
    R 28935 is an active compound.
    R 28935
  • HY-W687950
    β-Phenyl GHB sodium
    β-Phenyl GHB sodium is structurally similar to known CNS depressants.
    β-Phenyl GHB sodium
  • HY-119461
    Capuride
    Capuride is an orally active sedative agent. Capuride has anticonvulsant activity.
    Capuride
  • HY-134939
    thio-Miltefosine
    thio-Miltefosine is a modulator of rafts in membrane tissue. Rafts are nanoscale aggregates of different lipids and proteins that profoundly affect cellular function. Thio-Miltefosine modulates membrane phase behavior on cell-derived giant plasma membrane vesicles.
    thio-Miltefosine
  • HY-116656
    Oximino oxamyl
    Oximino oxamyl is an active compound.
    Oximino oxamyl
  • HY-110019A
    cis-Indatraline hydrochloride
    		99.64%
    cis-Indatraline (cis-Lu 19-005) hydrochloride is an active compound. cis-Indatraline (cis-Lu 19-005) hydrochloride can be used for the research of neurodegenerative diseases.
    cis-Indatraline hydrochloride